<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27760">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02745327</url>
  </required_header>
  <id_info>
    <org_study_id>PR14083</org_study_id>
    <nct_id>NCT02745327</nct_id>
  </id_info>
  <brief_title>Nutrition, Overgrowth, and Vaccine Efficacy in Low-income Settings</brief_title>
  <acronym>NOVEL</acronym>
  <official_title>A Longitudinal Study of Childhood Intestinal Bacterial Overgrowth, Vaccine Underperformance, and Malnutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the impact of small intestine bacterial overgrowth
      (SIBO) on childhood nutritional status, growth, and oral vaccine efficacy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose-Hydrogen Breath Test</measure>
    <time_frame>Birth to 2 years</time_frame>
    <description>Test for Small Intestine Bacterial Overgrowth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fecal Regenerating Islet-Derived 1 Beta (Reg 1B)</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Myeloperoxidase</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum 25-OH vitamin D</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Zinc</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Retinol Binding Protein</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Cobalamin</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Albumin</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactulose mannitol ratio</measure>
    <time_frame>12 weeks of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Tetanus antibody titers</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Polio antibody titers to sabin strains</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral fluid Tetanus antibody titers</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head circumference</measure>
    <time_frame>Birth to 2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">275</enrollment>
  <condition>Small Intestine Bacterial Overgrowth</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, stool, and urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Bangladeshi infants from the low-income neighborhood of Mirpur, Dhaka
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child previously enrolled in the FIELD STUDIES protocol (enrollments in both studies
             may occur simultaneously)

          -  Mother willing to sign informed consent form.

          -  Healthy infant aged less than 7 days old

        Exclusion Criteria:

          -  Parents are not willing to have child's blood drawn, oral fluid collected, urine
             collected, or breath testing performed.

          -  History of seizures, other apparent neurologic disorders, or other congenital
             abnormalities involving major organ systems.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William A Petri, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeffrey R Donowitz, MD</last_name>
    <phone>434-924-5621</phone>
    <email>jeffrey.donowitz@vcuhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>The International Centre for Diarrhoeal Disease Research, Bangladesh</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rashidul Haque, M.B., PhD</last_name>
      <phone>08829862896</phone>
      <email>rhaque@icddrb.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 25, 2016</lastchanged_date>
  <firstreceived_date>April 15, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oral vaccination</keyword>
  <keyword>nutrition</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
